Northern Trust’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.46M | Sell |
485,014
-2,029
| -0.4% | -$35.4K | ﹤0.01% | 2167 |
|
|
2025
Q1 | $6.13M | Buy |
487,043
+8,890
| +2% | +$112K | ﹤0.01% | 2314 |
|
|
2024
Q4 | $5.04M | Buy |
478,153
+25,773
| +6% | +$272K | ﹤0.01% | 2500 |
|
|
2024
Q3 | $6.56M | Buy |
452,380
+184,809
| +69% | +$2.68M | ﹤0.01% | 2320 |
|
|
2024
Q2 | $2.28M | Buy |
267,571
+5,462
| +2% | +$46.5K | ﹤0.01% | 2831 |
|
|
2024
Q1 | $2.68M | Buy |
262,109
+2,428
| +0.9% | +$24.8K | ﹤0.01% | 2814 |
|
|
2023
Q4 | $1.42M | Sell |
259,681
-1,459
| -0.6% | -$8K | ﹤0.01% | 3160 |
|
|
2023
Q3 | $987K | Buy |
261,140
+30,449
| +13% | +$115K | ﹤0.01% | 3303 |
|
|
2023
Q2 | $1.55M | Buy |
230,691
+158,721
| +221% | +$1.06M | ﹤0.01% | 3164 |
|
|
2023
Q1 | $469K | Buy |
71,970
+4,667
| +7% | +$30.4K | ﹤0.01% | 3496 |
|
|
2022
Q4 | $574K | Buy |
67,303
+28,019
| +71% | +$239K | ﹤0.01% | 3452 |
|
|
2022
Q3 | $207K | Buy |
39,284
+2,024
| +5% | +$10.7K | ﹤0.01% | 3860 |
|
|
2022
Q2 | $158K | Sell |
37,260
-136,309
| -79% | -$578K | ﹤0.01% | 4009 |
|
|
2022
Q1 | $609K | Sell |
173,569
-6,289
| -3% | -$22.1K | ﹤0.01% | 3665 |
|
|
2021
Q4 | $1.2M | Sell |
179,858
-5,889
| -3% | -$39.2K | ﹤0.01% | 3473 |
|
|
2021
Q3 | $1.85M | Buy |
185,747
+59,849
| +48% | +$597K | ﹤0.01% | 3330 |
|
|
2021
Q2 | $3.89M | Sell |
125,898
-8,686
| -6% | -$268K | ﹤0.01% | 2990 |
|
|
2021
Q1 | $5.87M | Buy |
+134,584
| New | +$5.87M | ﹤0.01% | 2656 |
|